EnhancerAtlas 2.0: an updated resource with typical enhancer annotation in 600 tissue/cell types across nine species

TagContent
EnhancerAtlas ID
HS110-02744 
Organism
Homo sapiens 
Tissue/cell
KATO3 
Coordinate
chr2:85664310-85666140 
TF binding sites/motifs
Number: 5             
TFJASPAR IDCoordinateMotif SequenceStrand-Log10(p-value)
KLF16MA0741.1chr2:85665114-85665125GGGGGCGGGGC-6.02
KLF4MA0039.3chr2:85665576-85665587CCACACCCTCC+6.32
KLF5MA0599.1chr2:85665115-85665125GGGGCGGGGC-6.02
LBX2MA0699.1chr2:85665325-85665335GCCAATTAGC+6.02
NR2C2MA0504.1chr2:85664988-85665003TGCCCTCCGACCCCG-6.33
Number of super-enhancer constituents: 29             
IDCoordinateTissue/cell
SE_00851chr2:85664354-85664594Adipose_Tissue
SE_00851chr2:85665679-85665949Adipose_Tissue
SE_01529chr2:85663480-85666708Adrenal_Gland
SE_03329chr2:85662175-85664878Brain_Angular_Gyrus
SE_03329chr2:85664969-85666959Brain_Angular_Gyrus
SE_04039chr2:85659765-85667780Brain_Anterior_Caudate
SE_05066chr2:85659776-85667840Brain_Cingulate_Gyrus
SE_05969chr2:85659679-85668106Brain_Hippocampus_Middle
SE_06962chr2:85659744-85667954Brain_Hippocampus_Middle_150
SE_08005chr2:85659743-85667963Brain_Inferior_Temporal_Lobe
SE_08853chr2:85663407-85664870Brain_Mid_Frontal_Lobe
SE_08853chr2:85665119-85666269Brain_Mid_Frontal_Lobe
SE_09675chr2:85663395-85667074CD14
SE_12755chr2:85665208-85665438CD34_fetal
SE_12755chr2:85665446-85665631CD34_fetal
SE_31856chr2:85659842-85666966Gastric
SE_33512chr2:85659775-85666880H2171
SE_34718chr2:85659757-85667655HeLa
SE_37700chr2:85659671-85666984HSMMtube
SE_40483chr2:85663522-85666339K562
SE_42809chr2:85659836-85666478Lung
SE_47420chr2:85659792-85666848Panc1
SE_47644chr2:85664072-85666224Pancreas
SE_49417chr2:85662161-85666850Right_Atrium
SE_50604chr2:85662226-85666450Sigmoid_Colon
SE_52950chr2:85663048-85666692Small_Intestine
SE_56638chr2:85663845-85666147u87
SE_65543chr2:85662091-85667108Pancreatic_islets
SE_69119chr2:85663010-85665329H9
Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder
Number of disease enhancers: 1             
ChromosomeStartEnd
chr28566454485665596
Enhancer Sequence
TTTAGATGCT CTGTGCCGAG CGAGGCCAGG CTGAGTGGCT GATTTTTGTT TTGATTTGTG 60
GGAGTTGGAG TGGGGAAGGG AGGGAGGCGC AGTGCTGTCT CTGACACCCT ATTAAATGAG 120
GAGAATGGAG TCCATTACCT ACTCCTCCAA CACCTACTTA CTGTACCTTG CTCCCGGGGG 180
AGTGATGAGC CTGATTTTGG GAGCTTGGTG TTGTCTAGAG GAGGGGAGAC AGTGGGCCCC 240
GGGAAACAAC TAGATCTGAT GCTCCAGTCT AGAGTCAAAG CTAGGGAAAG CTGAACAGTG 300
GCGCTCAGAG AAGACAGGAC AGCGGGCGAG AGCTTGGGGG GCGATGGGAG GTGGAGAGGC 360
ACTCCAGGTC CCCAGGGGGC CAGGCGGAGC TGCGGGACAG GGCGCAGACC CCGAGGCCCA 420
GGGAGCACCG GGTGGCCGGC GGCCTGCAGG CTGGCGAGGG CGTCGGGCGG CGCAGGGCAG 480
GCCAGGGGGC GGGGGCGTCT GGGGCCCTGG CGTGGCGCCC GGAACACCCC GTGCCGGAAG 540
CTCCATGTGA CCGTGACTCC GCAGAAGCCG CGAGCGCAGC GAAACAAAGG GCGGCTCTGC 600
GGCCGCCTCG AGCTCAGGCT GGCACCGAGG GCCCGGACCC CCATCCCACT CCGCACCCCC 660
GGGCCTCCCG GCCCTTCTTG CCCTCCGACC CCGGGCTCTG GCAGGGCCGG GAGGCGCAGG 720
AACCCCGCGG GGGATGGGGC CGGCGGACTG GCACTGAAGA CACTGGGATG CAAGCGGGAG 780
GCTGGGGGCG GGGGGCTGGG GGCGGGGGGC GGGGCTGCAG GGCGTGGACG GTCTCCGTCA 840
GTGCCGGCTC CTGCGGATTA CCGCCTCGGA ACCGTCATTT CTTGCCTGTA ATAAGGGGAA 900
GATAATCGTC CCTACGTAAT CGTCCTCCGG TTAGGAGGCT TAAGTGAGAC ATGCCACGTA 960
AAGGGATGCC TGCGTAAAGG GGTGCCTGAT GGGGAGAAGG AAACACCAAA TTCGGGCCAA 1020
TTAGCTGCCA CTGTCAAAAT CGCTGGGAAG ACACAGTTAT CGGCCAGGGC ACCAGGAAGG 1080
GGCACGGGCT GGGGCAGCCG TCATAGGGGT GGGGTGCGGG GGGCGGGTGG ACACCGGTGT 1140
GTGTATGTGA GGAAGGGACC AGCAGCGGAG GCCTCTAGCA GAAACAGGAG AATAGGAGAC 1200
CGGCAAGACA CGCCTTCAGC CCCACTGGCC CAGCCCTGGC TCCCTCCAGA ACCTGGCCTC 1260
CGTCCTCCAC ACCCTCCCCA GCATCATCCC GCAGGCCCGC AGGGGCTGTG GAGGCTGGGG 1320
AGCTTGGCAC CTTGGGCTGG GACTCAGGGT ACAGTCAGCC CCCTAGTATC CCCACAACAG 1380
CTCTACAGGT TCCACTTCCC TAGAGGAGCT CTCCACTCTG TGGCCACAAA GGCCTCGGGA 1440
CTCAGGGGCC TGTTGTTACT GAGCCCCGCA GCCATGAGGC ATTTGGTGGG GGAGTAGAAG 1500
TTACAGCCCA GAGCTCCTGA AGTTAATGGC CCAACAGGGA CTCTGATTTT TCCCAGCTTA 1560
GGGACTAACT TCAAGGAATT AGCCTCCATT CCTCCCCTCC CTGGGGAGAA AGAGAGGAGG 1620
AGCAGCTAGG CAGTGGGACA GTCTGTAACC CGGGCCCTTG AGGGCAAAAA GGAACCTGTT 1680
GCCTGCCCAG TACCTCCTCA GCTTGCAGGC CTGAGCAGAT GGCCCCTTGT CCAGGGAGCC 1740
TTCACCACTC CCCCAGCCTG GGCCCAGGTA CTTAGGCCGT CGTCTCTTCA CTCCCAGGAC 1800
AGACCGGCTA CTACTGCCCA CTATTGGATA 1830